The HIPOGAIA study: Monitoring of oral anticoagulation with vitamin K antagonists in the municipality of Gaia
Introduction: Anticoagulant therapy is an effective measure in preventing thromboembolic adverse events. Of the diseases in which this treatment is indicated, atrial fibrillation (AF) has the highest incidence worldwide, with a prevalence of 1.5-2%. Objectives: To assess the quality of monitoring of...
Main Authors: | Marta Guedes, Catarina Rego |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-09-01
|
Series: | Revista Portuguesa de Cardiologia (English Edition) |
Online Access: | http://www.sciencedirect.com/science/article/pii/S217420491630126X |
Similar Items
-
Estudo HIPOGAIA: monitorização da hipocoagulação oral com dicumarínicos no concelho de Gaia
by: Marta Guedes, et al.
Published: (2016-09-01) -
Non-Vitamin K Antagonist Oral Anticoagulants A Concise Guide
Published: (2016) -
Updates on Anticoagulation and Laboratory Tools for Therapy Monitoring of Heparin, Vitamin K Antagonists and Direct Oral Anticoagulants
by: Osamu Kumano, et al.
Published: (2021-03-01) -
Non-vitamin K Antagonist Oral Anticoagulants: Practise Essentials
by: Joana de Lemos Barata Garcia
Published: (2019) -
An Update on the Reversal of Non-Vitamin K Antagonist Oral Anticoagulants
by: Mark Terence P. Mujer, et al.
Published: (2020-01-01)